HIND
Vyome Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.22
−0.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 189.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.58x
- Price / sales
- 120.11x
- Price / cash flow
- 29.71x
Enterprise value
- Enterprise value
- $9.0M
- EV / sales
- 69.18x
- EV / EBITDA
- -0.78x
- EV / EBIT
- -2.13x
- Market cap
- $15.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026